Clinical Trials Logo

Filter by:
NCT ID: NCT03172936 Terminated - Clinical trials for Solid Tumors and Lymphomas

Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

Start date: September 8, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study was to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics and antitumor activity of MIW815 (ADU-S100) in combination with PDR001.

NCT ID: NCT03172832 Terminated - Cholangiocarcinoma Clinical Trials

A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors

INTERCPT
Start date: August 20, 2017
Phase: N/A
Study type: Interventional

The optimal approach to the drainage of malignant obstruction at the biliary hilum remains uncertain. This is a randomized comparative effectiveness study of percutaneous transhepatic biliary drainage (PTBD) vs. endoscopic retrograde cholangiography (ERC) as the first intervention in patients with cholestasis due to suspected malignant hilar obstruction.

NCT ID: NCT03172520 Terminated - Clinical trials for Parotid Gland Disorders

Automatic Periodic Stimulation and Continuous Electromyography (EMG) for Facial Nerve Monitoring During Parotidectomy

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to document the safety of the Medtronic automatic periodic stimulating (APS) Electrode Stimulator during a parotidectomy and potentially prevent post-operative facial nerve weakness, which is a relatively common outcome after parotid surgery.

NCT ID: NCT03172143 Terminated - Crohn Disease Clinical Trials

Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease

Start date: August 29, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if taking an increased sampling of mesentery (fatty tissue next to the intestine) and lymph nodes at the time of the subject's ileocolic resection prevents a 4-6 month recurrence of Crohn's disease at the site of the new connection.

NCT ID: NCT03172026 Terminated - Stroke Clinical Trials

Maraviroc to Augment Rehabilitation Outcomes After Stroke

MAROS
Start date: August 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

After stroke, the combination of progressive skills practice in an adequate dose, exercise for fitness, and reduced sedentary time will augment motor and cognitive outcomes. Sensorimotor and cognitive improvements after stroke often reach a general plateau by approximately 12 weeks after onset, however. Drugs that might enhance learning or neural repair, as well as other molecular and synaptic adaptations that occur during skills training and fitness exercise, might extend that recovery curve, although to date only fluoxetine has given any hint of this. Most trials have tested agents that modulate neurotransmitters. Several very recent preclinical experiments and observational studies in patients after stroke suggest that the commercially available medication, Maraviroc, a CCR5 antagonist, may augment skills learning during rehabilitation training, especially during the first three months after onset, by affecting CREB and synaptic plasticity. The investigators will carry out a randomized controlled trial of Maraviroc in patients with disabilities severe enough to have required inpatient stroke rehabilitation and, based on our preclinical data, who can start the drug intervention within 6 weeks of stroke onset. The investigators will compare usual post-stroke care plus placebo versus Maraviroc given for 8 weeks in 60 participants. However, to try to maximize the amount of practice that is most relevant to the primary outcome measurements and determine whether or not Maraviroc can enhance the effects of training, as hypothesized, all participants will be tele-monitored by mobile health devices and will receive weekly telephonic encouragement, based on device data, to walk, reduce sedentary time, and reach and grasp in the home in between usual care therapies. Compliance, serial motor changes over time, and self-management skills in making use of the telerehabilitation devices will be a nested substudy of feasibility of remote monitoring and feedback.

NCT ID: NCT03171168 Terminated - Knee Osteoarthritis Clinical Trials

The Effect of AposTherapy on Knee Pain

AposKnee
Start date: November 30, 2016
Phase: N/A
Study type: Interventional

AposTherapy is a home based exercise program utilizing footwear that causes exercise with normal activity that may significantly improve function in patients with knee osteoarthritis since patients with knee osteoarthritis have altered mechanics of motion contributing or due to the presence of the conditions. Capitalizing on the reported excellent adherence and clinical benefit of ApostTherapy in patients with significant knee OA, the investigators propose to evaluate this as a conservative treatment that may supplant/supplement traditional pain medications and physical therapy in an at-risk urban inner city population.

NCT ID: NCT03171051 Terminated - Lipolysis Clinical Trials

LED Device for Non-Invasive Lipolysis

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

This study is being conducted to evaluate the ability of a light emitting diode (LED) study device's ability to raise the temperatures on flank tissue to a similar level compared to an approved laser device (SculpSure by Cynosure). Laser treatments have been shown to reduce fat in the flanks by heating the fat cells and causing them to burst. The contents of the cells are then cleared naturally by the body.

NCT ID: NCT03170908 Terminated - Depressive Symptoms Clinical Trials

Effective Implementation of Interpersonal Psychotherapy

Start date: May 19, 2017
Phase:
Study type: Observational

The study is designed to observe the impact of improved measures of the fidelity on the community delivery of Interpersonal Psychotherapy. Pairs of therapist-patient dyads will be observed, first to develop and test brief measures of fidelity, and then to correlate those measures with symptomatic outcomes.

NCT ID: NCT03170869 Terminated - Clinical trials for Subjects Eligible for Liver Transplantation

Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE

SPEED
Start date: April 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study will be to prospectively evaluate the outcomes of patients with hepatocellular carcinoma (HCC) who undergo DEB-TACE (drug-eluting bead trans-arterial chemoembolization) with the Surefire Precision Infusion System for intentional effect of down-staging patients to OLT. Patients with HCC and who are considered candidates for liver transplantation but outside Milancriteria and meet the eligibility criteria will be enrolled in the prospective single arm study. Results of the prospective cohort will be compared to matched historical control patients who were previously treated with DEB-TACE, delivered with standard endhole catheters. This includes all patients treated at the University of Colorado since 2009 treated with 100-300 micron beads for whom follow-up is available.

NCT ID: NCT03170583 Terminated - Bradycardia Clinical Trials

SJM Brady MRI Post Approval Study

Brady MRI PAS
Start date: June 8, 2017
Phase:
Study type: Observational

The purpose of this post approval study is to evaluate the long-term safety of the FDA approved St. Jude Medical Tendril MRI™ lead implanted with a SJM Brady MRI implantable pulse generator (IPG) such as the Accent MRI™, Assurity MRI™, Endurity MRI™ pacemaker, or similar model (SJM Brady MRI System) in subjects with a standard bradycardia pacing indication.